Search Clinical Trials

589,087 trials

NCT07643870
Not Yet RecruitingPhase 1
Human ADME Study of [14C]-AZD1390AstraZeneca
NCT07643922
Not Yet RecruitingNot Applicable
Endovascular Therapy for Cerebral Vasospasm After Aneurysmal Subarachnoid HemorrhageBeijing Tiantan Hospital
NCT07644299
Not Yet RecruitingNot Applicable
Self-Hypnosis Training for Migraine Management (HYlaMI): A Pilot and Proof-of-Concept StudyCiusss de L'Est de l'Île de Montréal
NCT07644130
Not Yet RecruitingNot Applicable
Bergen Four-Day Treatment (B4DT) for Obsessive-Compulsive DisorderTampere University
NCT07646574
Not Yet Recruiting
Non-surgical Management After NIT for dMMR/MSI-H GCYong Zhou
NCT07644741
CompletedNot Applicable
Load-Matched Unilateral Versus Bilateral Squat Training in Elite Youth Futsal PlayersFederal University of Vicosa
NCT07645157
RecruitingPhase 2
Sertraline Combined With Multi-Strain Probiotics for Adolescent DepressionFirst Affiliated Hospital of Chongqing Medical University
NCT07645859
RecruitingNot Applicable
Comparison of High-Intensity Interval Training With Moderate-Intensity Continuous Training in Chronic Non-Specific Low Back Pain PatientsDow University of Health Sciences
NCT07646327
Not Yet RecruitingNot Applicable
Sustained Natural Apophyseal Glides With and Without Facilitated Positional Release Technique in Cervicogenic DizzinessRiphah International University
NCT07644026
Not Yet Recruiting
HBV Reactivation Prediction Model in Allo-HSCTInstitute of Hematology & Blood Diseases Hospital, China
NCT07644143
Not Yet RecruitingNot Applicable
Effect of A Theory-based Multicomponent eHealth Intervention ProgramTaipei Medical University
NCT07645248
Not Yet RecruitingPhase 3
A Study to Compare Safety of 4 Weeks Exposure to Propellants Hydrofluoroalkane 1,1-difluoroethane (HFA-152a) and HFA-1,1,1,2-tetrafluoroethane (134a)GlaxoSmithKline
NCT07644689
CompletedNot Applicable
Triple-Scan Protocol to Assess PassivityMansoura University
NCT07644754
Not Yet RecruitingNot Applicable
Patients With Metastasized Prostate Cancer Whose Prostate-specific Antigen-level (PSA) Remains >0,2 ng/ml After Six Months of Dual Antihormonal Therapy Will Receive Radiotherapy to the Prostate and Radiotherapy to Refractory MetastasesLudwig-Maximilians - University of Munich
NCT07645404
Not Yet RecruitingNot Applicable
The Effect of Mental Fatigue on Upper Extremity Functional PerformanceIzmir Bakircay University
NCT07644624
Not Yet RecruitingNot Applicable
Sling vs. Dynamic Shoulder Stabilizer After Soft Tissue Shoulder Instability Surgery (SLIDY)Hospital Universitari de Bellvitge
NCT07644897
RecruitingPhase 2
Thymosin Alpha 1 Combined With Anti-PD-1 Monoclonal Antibody in Elderly Patients With Advanced MelanomaSun Yat-sen University
NCT07644767
Not Yet RecruitingPhase 2
Adjunctive Oral KET-AD Capsules in Treatment Resistant Bipolar DepressionNeurocentrx Pharma Pty Ltd
NCT07645469
Not Yet RecruitingPhase 1
FH-WT1-E50 TCR T Cells With Azacitidine for the Treatment of Minimal Residual Disease Positive Acute Myeloid LeukemiaFred Hutchinson Cancer Center
NCT07646418
RecruitingNot Applicable
Combined Effects of LIRT-BFR Therapy in Post- Stroke PatientsRiphah International University